AUBRI VELEZ: Open Payments
NPI 1720621774 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 128 payments from 23 companies in 2025. Trend: 2023 $31 · 2024 $1,528 · 2025 $2,732
Food & beverage: $2,732
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $322 |
| GlaxoSmithKline, LLC. | 19 | $314 |
| Electromed, Inc. | 8 | $210 |
| GENZYME CORPORATION | 8 | $197 |
| Regeneron Healthcare Solutions, Inc. | 7 | $183 |
| Actelion Pharmaceuticals US, Inc. | 7 | $182 |
| Insmed, Inc. | 9 | $182 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $161 |
| Viatris Specialty LLC | 8 | $152 |
| Inspire Medical Systems, Inc. | 3 | $152 |
Products named: DUPIXENT, NUCALA, SMARTVEST, Arikayce, FASENRA, YUPELRI, INSPIRE, Ohtuvayre.
Industry payments across FL — which companies pay providers there.
